- Home
- RGC vs ENX Comparison
RGC vs ENX Comparison
Compare RGC & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- ENX
- Stock Information
- Founded
- RGC 2014
- ENX 2002
- Country
- RGC Hong Kong
- ENX United States
- Employees
- RGC N/A
- ENX N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- ENX Finance/Investors Services
- Sector
- RGC Health Care
- ENX Finance
- Exchange
- RGC Nasdaq
- ENX Nasdaq
- Market Cap
- RGC 105.3M
- ENX 175.5M
- IPO Year
- RGC 2021
- ENX N/A
- Fundamental
- Price
- RGC $4.86
- ENX $9.48
- Analyst Decision
- RGC
- ENX
- Analyst Count
- RGC 0
- ENX 0
- Target Price
- RGC N/A
- ENX N/A
- AVG Volume (30 Days)
- RGC 8.8K
- ENX 25.4K
- Earning Date
- RGC 10-25-2024
- ENX 01-01-0001
- Dividend Yield
- RGC N/A
- ENX 3.94%
- EPS Growth
- RGC N/A
- ENX N/A
- EPS
- RGC N/A
- ENX 0.16
- Revenue
- RGC N/A
- ENX N/A
- Revenue This Year
- RGC N/A
- ENX N/A
- Revenue Next Year
- RGC N/A
- ENX N/A
- P/E Ratio
- RGC N/A
- ENX $61.00
- Revenue Growth
- RGC N/A
- ENX N/A
- 52 Week Low
- RGC $3.03
- ENX $7.84
- 52 Week High
- RGC $32.44
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- RGC 44.96
- ENX 41.09
- Support Level
- RGC $4.75
- ENX $9.42
- Resistance Level
- RGC $5.21
- ENX $9.89
- Average True Range (ATR)
- RGC 0.30
- ENX 0.12
- MACD
- RGC 0.04
- ENX -0.01
- Stochastic Oscillator
- RGC 23.87
- ENX 29.35
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.